Moody’s affirms ‘A2’ rating on WakeMed

Moody’s Investors Service affirmed its “A2” long-term rating on Raleigh, N.C.-based WakeMed, affecting about $390 million of debt.

Advertisement

The affirmation is a result of several factors, including the health system’s favorable service area, growing cash flow margins and consistent operating performance.

The outlook is stable, reflecting Moody’s expectation that the health system’s cash flow will remain strong as WakeMed invests in facilities and services to stay competitive.

More articles on healthcare finance:
Missouri to hospitals: Contract with 3 managed Medicaid insurers or face 10% payment cut
2 Arkansas hospitals accuse EMS provider of balance billing
13 latest hospital credit rating downgrades

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.